• antithrombin
  • Apixaban was added to plasma from healthy subjects in the concentration range 0-1000 μg L(-1) , and analyses were performed with different reagents for activated partial thromboplastin time (APTT), prothrombin time (PT), antithrombin, protein C, and protein S. A lupus anticoagulant assay and an APTT assay with varying phospholipid concentrations were used to study the phospholipid dependence. (diva-portal.org)
  • effects
  • The purpose of this study was to examine the effects of early and delayed processing on TEG ® parameters using kaolin-activated citrated blood samples in the intensive care population. (wiley.com)
  • Laboratory monitoring is not necessary, but the effects on common coagulation reagents and assays constitute clinically valuable information. (diva-portal.org)
  • To investigate the effects of apixaban on commonly used coagulation methods, and to evaluate anti-FXa assays for specific determination of the drug concentration. (diva-portal.org)